Science Explorer Back to mapMap
Discussion
Researcher · Integra (United States) · United States

Mike Gart

Mike Gart publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Cancer Research, on topics such as Lung Cancer Treatments and Mutations, Advanced Breast Cancer Therapies and HER2/EGFR in Cancer Research.

OpenAlex
World rank
#3,626,117
of 7,710,434 ranked researchers
Rank in United States
#1,007,835
of 1,627,098
Works
55
Citations
81
Citations per work
1.5
h-index
3
i10-index 1Top 95% in Pulmonary and Respiratory Medicine
Mike Gart

What does Mike Gart research?

Mike Gart's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (7%), Economics, Econometrics and Finance (3%).

Health Sciences: 34 works · 62.1% of their workMedicine: 34 works · 62.1% of their workPulmonary and Respiratory Medicine: 15 works · 27.7% of their workOncology: 13 works · 24.3% of their workGenetics: 3 works · 5.4% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 4.7% of their workEverything else: 15 works · 27.1% of their workLife Sciences: 4 works · 7.4% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 7.4% of their workCancer Research: 4 works · 7.4% of their workSocial Sciences: 2 works · 3.4% of their workEconomics, Econometrics and Finance: 2 works · 3.4% of their workEconomics and Econometrics: 2 works · 3.4% of their workTHEIR WORKMike Gart55works
Life Sciences7%Health Sciences62%Social Sciences3%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine3462.1%
  2. Everything else1527.1%
    1. Biochemistry, Genetics and Molecular Biology47.4%
    1. Economics, Econometrics and Finance23.4%
  1. 1Pulmonary and Respiratory Medicine28% of their works
  2. 2Oncology24% of their works
  3. 3Cancer Research7% of their works
  4. 4Genetics5% of their works
  5. 5Radiology, Nuclear Medicine and Imaging5% of their works
  6. 6Economics and Econometrics3% of their works

Research topics

Which keywords describe Mike Gart's research?

The keywords of their largest research topics: Breast Cancer, Genomic Profiling, Targeted Therapy, Chemotherapy, ALK Inhibitors, CDK4/6 Inhibitors, EGFR Mutations and Palbociclib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Breast Cancer202 topics
  2. Genomic Profiling192 topics
  3. Targeted Therapy192 topics
  4. Chemotherapy172 topics
  5. ALK Inhibitors111 topic
  6. CDK4/6 Inhibitors111 topic
  7. EGFR Mutations111 topic
  8. Palbociclib111 topic
  9. HER291 topic
  10. Trastuzumab91 topic
  11. Androgen Receptor81 topic
  12. BRCA Mutation81 topic
  13. CT Screening81 topic
  14. Cancer Genomics81 topic
  15. Chronic Lymphocytic Leukemia81 topic
  16. Genomic Aberrations81 topic
  17. Lung Cancer81 topic
  18. Mutational Signatures81 topic
  19. PARP Inhibitors81 topic
  20. Prostate Cancer81 topic

Where does Mike Gart work?

Mike Gart's main affiliation in the publication record is Integra (United States), United States.

How many publications and citations does Mike Gart have?

OpenAlex counts 55 works and 81 citations for Mike Gart, an h-index of 3, ranking #3,626,117 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mike Gart. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.